Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131888) titled 'Effect of tegileridine on cough-related pain after thoracoscopic lung surgery: a single-center, randomized, double-blind, parallel-group controlled trial' on Sept. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Cough-related pain after thoracoscopic lung surgery
Intervention:
Sufentanil group:At the time of chest closure, sufentanil 0.2 µg/kg (maximum dose 15 µg
for patients aged = 65 years, maximum dose 10 µg)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Ta...